Integra LifeSciences Holdings Corporation announced that CFO Lea Knight will present at the 2026 UBS Global Healthcare Conference on November 9, 2026. The presentation will be webcast live on the company's investor relations website. This event highlights Integra's ongoing engagement with investors and its leadership in medical technology, particularly in neurosurgery and tissue reconstruction. Investors can expect updates on the company's strategic direction and innovations during the presentation.
Integra LifeSciences' upcoming presentation at the 2026 UBS Global Healthcare Conference is noted here with Pluang's health sector market data as of Nov 06, 2026 19:41 WIB. Of 150 priced health-sector US stocks tradable on Pluang, 52 rose and 90 fell today. Notable movers include TransMedics Group Inc (TMDX) at USD 77.25 with a 1-day change of +11.99% and 100% buy order activity, and Brookdale Senior Living Inc (BKD) at USD 9.40 down 13.04%.
Nexans has signed a subcontract to deliver a 420 km mass-impregnated 110 kV cable system for the 1 GW, 320 kV Corinth-Kos HVDC interconnection in Greece. This project, awarded to Hellenic Cables and partners, will connect the Dodecanese islands to ma...
Guggenheim analyst Howard Ma raised JFrog's price target to $125, signaling a 67.5% potential upside from its current price of $74.62. JFrog reported strong Q3 2026 results with revenue up 31% year-over-year to $179.2 million, driven by a 60% surge i...
The Indonesia data center market is projected to grow from USD 2.08 billion in 2027 to USD 4.05 billion by 2032, at a CAGR of 14.28%. Growth is fueled by expanding hyperscaler cloud infrastructure, rising digital workloads, increasing demand for colo...
Investing $300,000 equally in three high-dividend stocks—Realty Income, Verizon, and Ares Capital—can yield over $21,500 in passive income annually. Realty Income offers a 5.53% yield with monthly dividends from net-lease properties, Verizon provides...
Paycom Software, Inc. reported strong Q3 2026 results, with revenue up 10% year-over-year and non-GAAP EPS increasing by 37%. The company's adjusted EBITDA margin expanded to 49.3%, and recurring revenue reached 95.5% of total, driven by successful u...
